The evolution of the HIV-1 integrase through constraints from folding stability and functional interactions
En palabras de los autores
The rapid evolution of human immunodeficiency virus type 1 (HIV-1) facilitates the emergence and fixation of drug-resistance mutations (DRMs). Although variants carrying DRMs gain a selective advantage under antiretroviral treatment, these mutations may compromise protein fitness, affecting viral replication efficiency and shaping evolutionary trajectories. Understanding the emergence, fixation, and fitness effects of DRMs is therefore essential for predicting evolutionary outcomes and optimizing therapies. Here, we investigated the evolution of the HIV-1 integrase, a key antiretroviral target, and the influence of common DRMs by analyzing folding stability, DNA substrate binding affinity, and structural properties across integrase variants using long molecular dynamics simulations combined with protein phylogenetic inference. DRMs generally altered protein folding stability and protein-DNA interactions to a marginal extent, due to their number, position, and physicochemical properties. Several DRMs altered catalytic site geometry, including alteration of magnesium coordination within the catalytic triad and modulation of enzymatic activity by changes in flexibility of the 140-149 loop involved in substrate binding, while others had minor effects on DNA binding. Over long evolutionary timescales, temporal fluctuations in folding stability and DNA-binding affinity were observed, potentially driven by alternating diversification and selection regimes at molecular and population levels. We conclude that HIV-1 integrase evolves under marginal stability, allowing structural variation that supports adaptation while preserving essential activity, which should be considered in predictions of structural evolutionary trajectories. Together, integrating biophysical properties with evolutionary modeling provides a robust framework for understanding how structural constraints influence the fixation of adaptive mutations.
Apareció: miércoles, 18 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.